NO953647L - Veterinær-medikament med forlenget frigjöring - Google Patents

Veterinær-medikament med forlenget frigjöring

Info

Publication number
NO953647L
NO953647L NO953647A NO953647A NO953647L NO 953647 L NO953647 L NO 953647L NO 953647 A NO953647 A NO 953647A NO 953647 A NO953647 A NO 953647A NO 953647 L NO953647 L NO 953647L
Authority
NO
Norway
Prior art keywords
extended release
veterinary drug
carrier material
gelling agent
fatty acid
Prior art date
Application number
NO953647A
Other languages
English (en)
Other versions
NO953647D0 (no
Inventor
Alan Patterson
Drew Holmes
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of NO953647D0 publication Critical patent/NO953647D0/no
Publication of NO953647L publication Critical patent/NO953647L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Veterinær-blanding med vedvarende frigjøring for intramuskulær og subkutan tilferesl omfattende "Tylosin" og et oljeaktig bærermateriale inneholdende et geldannende middel, hvor det geldannende middel kan være et aluminium- salt av en fettsyre såsom stearinsyre og det oljeaktige bærermateriale kan være en lav-viskositets polyol-diester av en kortkjedet naturlig avledet fettsyre såsom propylen- glykol-dikaprylat/dikaprat.
NO953647A 1993-03-24 1995-09-15 Veterinær-medikament med forlenget frigjöring NO953647L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306106A GB9306106D0 (en) 1993-03-24 1993-03-24 Sustained release veterinary composition
PCT/GB1994/000578 WO1994021267A1 (en) 1993-03-24 1994-03-22 Tylosin containing sustained release veterinary compositions

Publications (2)

Publication Number Publication Date
NO953647D0 NO953647D0 (no) 1995-09-15
NO953647L true NO953647L (no) 1995-11-22

Family

ID=10732660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953647A NO953647L (no) 1993-03-24 1995-09-15 Veterinær-medikament med forlenget frigjöring

Country Status (23)

Country Link
EP (1) EP0689444B1 (no)
JP (1) JPH08508032A (no)
KR (1) KR100283369B1 (no)
CN (1) CN1096268C (no)
AT (1) ATE181834T1 (no)
AU (1) AU669435B2 (no)
BG (1) BG62352B1 (no)
BR (1) BR9406202A (no)
CA (1) CA2158662C (no)
DE (1) DE69419408T2 (no)
DK (1) DK0689444T3 (no)
ES (1) ES2135568T3 (no)
FI (1) FI954447A7 (no)
GB (1) GB9306106D0 (no)
GR (1) GR3031293T3 (no)
HU (1) HUT73424A (no)
IL (1) IL109053A (no)
NO (1) NO953647L (no)
NZ (1) NZ262756A (no)
PE (1) PE7595A1 (no)
PL (1) PL175127B1 (no)
RO (1) RO114738B1 (no)
WO (1) WO1994021267A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
PL208585B1 (pl) * 2002-10-25 2011-05-31 Intervet Int Bv Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca cefquinom, sposób jej wytwarzania i zastosowanie cefquinomu
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
CN116407505B (zh) * 2023-03-28 2025-09-19 青岛康地恩动物药业有限公司 一种高生物利用度泰万菌素干混悬剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
NZ203684A (en) * 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
ES2024444B3 (es) * 1986-03-10 1992-03-01 American Cyanamid Co Metodo para la preparacion de formulacion de pildoras gruesas de liberacion sostenida.

Also Published As

Publication number Publication date
EP0689444A1 (en) 1996-01-03
PE7595A1 (es) 1995-04-25
KR960700732A (ko) 1996-02-24
KR100283369B1 (ko) 2001-03-02
DK0689444T3 (da) 1999-11-22
IL109053A0 (en) 1994-06-24
BR9406202A (pt) 1995-12-12
PL175127B1 (pl) 1998-11-30
JPH08508032A (ja) 1996-08-27
BG62352B1 (bg) 1999-09-30
GR3031293T3 (en) 1999-12-31
DE69419408T2 (de) 1999-10-28
RO114738B1 (ro) 1999-07-30
HU9502700D0 (en) 1995-11-28
FI954447A0 (fi) 1995-09-20
CN1096268C (zh) 2002-12-18
BG100078A (bg) 1996-07-31
DE69419408D1 (de) 1999-08-12
WO1994021267A1 (en) 1994-09-29
ATE181834T1 (de) 1999-07-15
HUT73424A (en) 1996-07-29
PL310804A1 (en) 1996-01-08
CN1123525A (zh) 1996-05-29
IL109053A (en) 1999-09-22
CA2158662C (en) 2009-06-30
FI954447L (fi) 1995-11-15
NO953647D0 (no) 1995-09-15
GB9306106D0 (en) 1993-05-12
FI954447A7 (fi) 1995-11-15
ES2135568T3 (es) 1999-11-01
EP0689444B1 (en) 1999-07-07
CA2158662A1 (en) 1994-09-29
AU6262194A (en) 1994-10-11
AU669435B2 (en) 1996-06-06
NZ262756A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
FI872481A0 (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
ATE222500T1 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
CA2259297A1 (en) Parenteral paclitaxel in a stable non-toxic formulation
ITMI922603A1 (it) Composizioni farmaceutiche comprendenti un farmaco, una sostanza polimerica reticolata, un olio ed un agente tensioattivo
MX9602955A (es) Procedimiento para solubizar activos farmaceuticos dificilmente solubles.
IT1279383B1 (it) Composizione farmaceutica stabilizzata contenente un agente antineoplastico degradabile, relativo solvente stabilizzante avente
FI935396L (fi) Uudet nanopartikkelien muodossa olevat, veren röntgenvarjoainekoostumukset, joissa on suuren molekyylipainon pinta-aktiivista ainetta
EP0782855A4 (en) ANTI-INFLAMMATORY AGENT FOR EXTERNAL USE
ES2084174T3 (es) Productos y procesos para el tratamiento del conducto alimentario.
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
AR043071A1 (es) Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
ES2163147T3 (es) Perfeccionamientos de agentes antimicrobianos de accion prolongada o relativos a los mismos.
DK305087A (da) Buprenorphinholdigt farmaceutisk suppositorium
NZ236474A (en) 4,5-diphenyl-2-oxazole octanoic, nonanoic and decanoic acid and ester derivatives, preparation and pharmaceutical compositions thereof
NO953647D0 (no) Veterinær-medikament med forlenget frigjöring
MY110074A (en) Pharmacuetical formulation.
IL93721A0 (en) Mixed micelles compositions and their use as carriers for the parenteral application of the drugs
HU9303246D0 (en) Pharmaceutical compositions containing purpurogallin as antioxidant and citoprotective agent
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application